GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (LTS:0QIU) » Definitions » 5-Year Yield-on-Cost %

Novo Nordisk AS (LTS:0QIU) 5-Year Yield-on-Cost % : 3.05 (As of Jan. 18, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Novo Nordisk AS 5-Year Yield-on-Cost %?

Novo Nordisk AS's yield on cost for the quarter that ended in Sep. 2024 was 3.05.


The historical rank and industry rank for Novo Nordisk AS's 5-Year Yield-on-Cost % or its related term are showing as below:

LTS:0QIU' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.37   Med: 3.12   Max: 7.35
Current: 3.05


During the past 13 years, Novo Nordisk AS's highest Yield on Cost was 7.35. The lowest was 1.37. And the median was 3.12.


LTS:0QIU's 5-Year Yield-on-Cost % is ranked better than
63.06% of 509 companies
in the Drug Manufacturers industry
Industry Median: 2.25 vs LTS:0QIU: 3.05

Competitive Comparison of Novo Nordisk AS's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Novo Nordisk AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk AS's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Novo Nordisk AS's 5-Year Yield-on-Cost % falls into.



Novo Nordisk AS 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Novo Nordisk AS is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Novo Nordisk AS  (LTS:0QIU) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Novo Nordisk AS 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk AS Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, 2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines